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Research Article

Paxilline inhibits BK channels by an almost exclusively closed-channel
block mechanism
Yu Zhou and Christopher J. Lingle

Paxilline, a tremorogenic fungal alkaloid, potently inhibits large conductance Ca2+- and voltage-activated K+ (BK)type channels, but little is known about the mechanism underlying this inhibition. Here we show that inhibition is
inversely dependent on BK channel open probability (Po), and is fully relieved by conditions that increase Po, even
in the constant presence of paxilline. Manipulations that shift BK gating to more negative potentials reduce inhibition by paxilline in accordance with the increase in channel Po. Measurements of Po times the number of channels
at negative potentials support the idea that paxilline increases occupancy of closed states, effectively reducing the
closed–open equilibrium constant, L(0). Gating current measurements exclude an effect of paxilline on voltage
sensors. Steady-state inhibition by multiple paxilline concentrations was determined for four distinct equilibration
conditions, each with a distinct Po. The IC50 for paxilline shifted from around 10 nM when channels were largely
closed to near 10 µM as maximal Po was approached. Model-dependent analysis suggests a mechanism of inhibition in which binding of a single paxilline molecule allosterically alters the intrinsic L(0) favoring occupancy of
closed states, with affinity for the closed conformation being >500-fold greater than affinity for the open conformation. The rate of inhibition of closed channels was linear up through 2 µM paxilline, with a slope of 2 × 106 M1s1.
Paxilline inhibition was hindered by either the bulky cytosolic blocker, bbTBA, or by concentrations of cytosolic
sucrose that hinder ion permeation. However, paxilline does not hinder MTSET modification of the inner cavity
residue, A313C. We conclude that paxilline binds more tightly to the closed conformation, favoring occupancy of
closed-channel conformations, and propose that it binds to a superficial position near the entrance to the central
cavity, but does not hinder access of smaller molecules to this cavity.
INTRODUCTION

Since the early days of investigation of ion channel
function to the present day in which functional studies
of ion channels are also guided by structural information, molecules that inhibit ion channels continue to be
essential tools for probing state-dependent conformational changes in binding-site accessibility. For potassium channels (K+ channels), some of the earliest work
with channel blockers insightfully established that statedependent conformational changes on the cytosolic
side of voltage-dependent K+ channels are required to
allow charged quaternary blockers to reach their block
ing position within the pore (Armstrong, 1969; Armstrong
and Hille, 1972; Choi et al., 1991). Furthermore, for
many Kv channels, channel closure can only occur after
exit of the blocker from its blocking position (Armstrong
and Hille, 1972; Choi et al., 1993). This idea that there
is gated access to the permeation pathway from the cytosolic side of K+ channels was subsequently born out in
structures of K+ channels (Doyle et al., 1998; Long et al.,
Correspondence to Christopher J. Lingle: clingle@morpheus.wustl.edu
Abbreviations used in this paper: bbTBA, N-(4-[benzoyl]benzyl)-N,N,Ntributylammonium; BK, large conductance Ca2+- and voltage-activated K+;
ChTX, charybdotoxin; C-O, closed–open; MTSEA, 2-aminoethyl MTS;
MTSES, sodium (2-sulfanoethyl) MTS; MTSET, [2-(trimethylammonium)
ethyl] MTS bromide; NPo, open probability times the number of channels; Pc, closed probability; Po, open probability.
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2005; Uysal et al., 2009). First, in closed K+ channels,
the so-called crossing of the S6 helices provides a physical barrier to access of small molecules to an inner aqueous cavity preceding the selectivity filter. Second, in open
K+ channels, separation of the S6 helices creates an
aperture (Perozo et al., 1999) that allows access not
only of permeant ions but also of quaternary blockers
(Lenaeus et al., 2005) and peptides (Zhou et al., 2001)
to positions within the inner cavity. Together, these
types of functional and structural tests have provided a
compelling picture of a category of channel inhibition
that exclusively involves open-channel block; that is,
binding sites for particular blockers only become available when the channel is open. However, ion channel
inhibition can also occur by a variety of other mechanisms, which can also be informative about channel
function and its structural components. One particularly
rich source of interesting channel blockers are naturally
occurring toxins.
Evolutionary pressures for species to optimize their
survival have resulted in a vast, useful, and only partially
exploited array of naturally occurring compounds that
© 2014 Zhou and Lingle This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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2009) that are potent nonpeptidergic blockers of BK
channels, generally acting at low nanomolar concentrations (Knaus et al., 1994; Imlach et al., 2009). Because
some BK channels containing particular auxiliary  subunits exhibit resistance to block by the BK-blocking
scorpion toxins, iberiotoxin and ChTX (Xia et al., 1999;
Meera et al., 2000; Xia et al., 2000), paxilline, as a more
general BK inhibitor, is often used in tests of physiological roles of BK channels (Shao et al., 1999; Raffaelli
et al., 2004; Tammaro et al., 2004; Essin et al., 2009).
Although inhibition by paxilline has been termed allosteric and shows relief by elevations of Ca2+ (Sanchez
and McManus, 1996), the mechanism and site of action
of the lipophilic paxilline are unknown. Recently, we
observed that mutation of the so-called hinge glycine
position (G311) in the S6 helix thought to line the BK
channel inner cavity totally abolishes paxilline inhibition (Zhou et al., 2010). This suggests that paxilline
block is associated in some way with the BK pore-gate
domain, perhaps dependent in some way on the conformational status of the inner pore. Here, we establish
that paxilline inhibition can best be viewed as an allosteric effect on the BK channel closed–open (C-O) equilibrium, stabilizing channels in closed conformations,
while having no discernible direct blocking effect on
open BK channels and no effect on voltage sensors. Occupancy of the paxilline-binding site does not directly
occlude ion permeation, but binding shifts the channel
C-O equilibrium, resulting in stabilization of channels
in closed states.
MATERIALS AND METHODS
General methods
Oocyte preparation, handling of RNA, and electrophysiological
methods used here were identical to those described in other recent papers from this laboratory (Tang et al., 2009; Zhou et al.,
2010). All experiments used excised inside-out patches in which
solution exchange at the pipette tip was accomplished with a fast
perfusion stepper system (SF-77B; Warner Instruments). Pipettes
were typically 1–2 MΩ, except for patches used for open probability (Po) times the number of channels (NPo) or gating current
measurements, and were coated with Sylgard (Sylgard 184; Corning) before heat polishing. Gigaohm seals were formed while the
oocytes were bathed in frog Ringer’s solution (mM: 115 NaCl, 2.5
KCl, 1.8 CaCl2, and 10 HEPES, pH 7.4). After patch excision, the
pipette tip was moved into flowing test solutions. The pipette solution (bathing the extracellular membrane face) contained (mM):
140 K-methanesulfonate, 20 KOH, 10 HEPES, and 2 MgCl2,
pH 7.0. The composition of the solution used to bathe the cytoplasmic face of patch membranes was (mM): 140 K-methanesulfonate, 20 KOH, and 10 HEPES, with pH adjusted to 7.0. For 0 Ca2+,
the solution also contained 5 mM EGTA; for 10 µM Ca2+, it contained 5 mM HEDTA; and for 100 or 300 µM Ca2+, no Ca2+ buffer
was included. For 10 µM Ca2+, the solution was titrated with a Ca2+methanesulfonate solution to obtain the desired Ca2+ concentration (Zhang et al., 2001), as defined with a Ca2+-sensitive electrode
calibrated with commercial Ca2+ solutions (WPI). Measurements
and fitting of current recordings were accomplished either with
Clampfit (Molecular Devices) or with programs written in this
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may kill or incapacitate prey or limit predation (Bush
et al., 1997; Han et al., 2008; Liang, 2008). Such compounds often target ion channels, and the high selectivity and strong affinity for particular ion channels have
proven of enormous value for the identification of particular subtypes of ion channels and their physiological
roles. Many such toxins are thought to act simply by
binding to the extracellular face of an ion channel, perhaps in a largely state-independent fashion, thereby
occluding ion permeation or preventing channel openings. This would include toxins such as tetrodotoxin
acting on Na+ channels (Narahashi et al., 1964, 1967),
charybdotoxin (ChTX) acting on large conductance
Ca2+- and voltage-activated K+ (BK)-type K+ channels
(Smith et al., 1986; Anderson et al., 1988; MacKinnon
and Miller, 1988), and agitoxin acting on voltagedependent K+ channels (Gross and MacKinnon, 1996).
Recent structural work has now specifically defined the
complex of ChTX in association with the Kv2.1 paddleKv1.2 chimeric channel (Banerjee et al., 2013). Over
the past several years, another category of naturally occurring toxin has been identified that selectively targets
voltage-sensor domains of K+ channels, inhibiting channels by stabilizing voltage-sensor domains in resting
conformations (Swartz and MacKinnon, 1997a,b; Lee
and MacKinnon, 2004; Milescu et al., 2009; Wang et al.,
2011). The ability of toxins to target not only specific
ion channels but also specific functional domains of ion
channels suggests that additional channel inhibitory
mechanisms may remain to be revealed.
Some channel-blocking agents, for which detailed
mechanistic information remains incomplete, have been
termed “allosteric blockers” or “closed-channel blockers.” Such descriptions simply imply that a binding site
and mechanism exist, different from direct physical
occlusion of the permeation pathway, that maintains
channels in nonconducting states. The voltage-sensor
toxins, in fact, would fall in this category: they maintain
voltage sensors in resting states, thereby allosterically
preventing channel opening. However, in most cases
for which a channel inhibitory mechanism has been
termed allosteric, the specific details of how drug binding is related to channel inhibition remain unclear.
One example of such a poorly understood allosteric
blocking mechanism is the inhibition of BK-type K+
channels by the naturally occurring fungal alkaloid,
paxilline (Knaus et al., 1994; Sanchez and McManus,
1996; Imlach et al., 2009). The BK channel is a particularly attractive target for elucidation of an allosteric
blocking mechanism, because the well-developed framework that describes allosteric regulation of BK channels
(Horrigan and Aldrich, 2002) allows one to assess which
part of the BK gating apparatus may be influenced by
a compound.
Paxilline is one of a variety of fungal indole alkaloids
(Cole and Cox, 1981; Knaus et al., 1994; Imlach et al.,
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laboratory. Experiments were performed at room temperature
(22–25°C).
NPo measurements. For determination of NPo at negative potentials, patches were pulled from oocytes expressing large numbers of BK channels. Openings were determined with the
threshold-based single-channel search function of Clampfit 9,
and total amplitude histograms were generated from the current
records. A fit of a Gaussian function to the total amplitude histograms was used to estimate NPo under various concentrations
of paxilline.

the control G-V curves, scaled by the fraction of unblocked channels (fun) at any given equilibration potential. For Scheme 1,
fun(pax) = (O + C + Op)/(O + C + Op + Cp). For Scheme 2 with no
open-blocked channels, fun(pax) = (O + C)/(O + C + Cp). For
Scheme 3, the fraction of unblocked channels is given by: fun(pax) =
(O + C)/(O + C + Cp + Bp).

Gating current measurements. Gating currents were recorded
from inside-out macropatches (10–20 µM in diameter). The pipette solution contained (mM):127 tetraethylammonium hydroxide, 125 methanesulfonic acid, 2 MgCl2, and 10 HEPES,
pH 7.0. The internal solution contained (mM): 141 NMDG, 135
methanesulfonic acid, 10 HEPES, and 5 EGTA, pH 7.0. Voltage
commands were filtered at 20 kHz with an eight-pole Bessel filter (Frequency Devices) to avoid saturation by fast capacitive
transients (Horrigan and Aldrich, 1999). Gating currents were
filtered at 10 kHz with the internal filter of the Axopatch and
sampled at 100 kHz. Capacitive transients and leak currents
were subtracted using a P/5 protocol with a holding potential
of 80 mV.

(Scheme 1)

Estimates of block parameters. Both the onset of block and recovery from block by paxilline occur slowly, with time constants
on the order of seconds. Furthermore, block by paxilline exhibits
no voltage dependence during the time course of typical voltage
steps used to define activation of conductance as a function of
voltage. Thus, as will be more strongly developed in the Results,
the fractional block under any condition reflects the state dependence of paxilline block established at the specific holding potential and Ca2+ concentration before any change in activation
voltage. Together, we term the particular holding potential and
Ca2+ concentration during which paxilline block equilibrates as
the “equilibration condition.” We consider three general schemes
of state-dependent block. In Scheme 1, paxilline binds to both
open and closed BK channels, but paxilline-bound open BK
channels are able to conduct current, with inhibition resulting
from stabilization of the paxilline-bound closed state. This corresponds to allosteric regulation of the BK C-O intrinsic gating
equilibrium, governed by coupling constant, Ep, representing the
change in the C-O equilibrium when paxilline is bound (binding
equilibrium constant, Kp). In Scheme 2, paxilline only binds to
closed BK channels, thereby increasing occupancy in closed
states. Scheme 2 is a limiting case of Scheme 1, with coupling
constant Ep <<< 1. In Scheme 3, paxilline binds and blocks both
open and closed BK channels. As we will establish, the paxillineblocking equilibrium is essentially unchanged during test sequences that are used to define G-V curves. Therefore, for any
scheme, the G-V curves generated from brief test steps in the presence of paxilline will reflect only the contributions of the unblocked channels available at any given equilibration condition.
Thus, a G-V curve in the presence of paxilline will be defined by


(Scheme 2)

(Scheme 3)
As in previous work (Tang et al., 2009), control G-V curves were
fit based on a standard allosteric model of BK channel activation
(Horrigan and Aldrich, 2002). Specifically, we describe the control G-V with
Po (V ) =

1
,
1+ L

where
4

 1   1 + J + K + JKE 
L =  
 ,
 L   1 + JD + KC + JDKCE 
where L, K, and J represent the C-O equilibrium, Ca2+-binding
equilibrium, and the voltage-sensor equilibrium, respectively,
with D, C, and E representing coupling between J and L, coupling
between K and L, and coupling between J and K, respectively.
After definition of constants suitable to describe the control G-V
Zhou and Lingle
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Constructs. The mSlo1 construct containing the coding region of
mSlo1 (GenBank accession no. NM_010610; provided by L. Salkoff,
Washington University School of Medicine, St. Louis, MO) was
subcloned into the pXMX oocyte expression vector (Tang et al.,
2009). For experiments involving MTS reagents, the control Slo1
construct contained the C430S mutation, which abolishes a shift
in gating produced in WT Slo1 channels by MTS reagents (Zhang
and Horrigan, 2005). The A313C and A316C mutations were as
described previously (Zhou et al., 2011).
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curves, these parameters were then constrained, while parameters for blocking schemes were defined.
Given that no changes in the paxilline-blocking equilibrium
occur during the duration of voltage steps used to test BK activation, the predicted dependence of the G-V curve for any scheme
in the presence of paxilline will be given by

potential. Hence, for Scheme 1, where Imax reflects maximal
activation,
		

(4)

(

2+

)

1 + Lhp +

I pax I max = f un Ca , hp , pax =
1
G (V ) =
f un ( pax ) .
1+ L
With the paxilline affinity to the closed channel given by Kp, the
open-state affinity, Kp(o), is Kp/Ep. For Scheme 1, in which the binding of paxilline allosterically regulates the C-O equilibrium constant, L, favoring stabilization of closed states, open channels,
although able to bind paxilline, remain conducting with:
1 + Lhp +

f un ( Pax , hp ) =

E p [ Pax ]
Kp

+ Lhp

1+
NPo pax NPo 0 pax =

[Pax ]

,

(1)

Kp

f un ( Pax , hp ) =

1 + Lhp + Lhp

[Pax ]

.

(2)

Kp

For Scheme 3, in which paxilline can bind to both open and
closed channels and the bound-open channel is nonconducting,
f un ( Pax , hp ) =
1 + Lhp +

1 + Lhp
E p [ Pax ]
Kp

+ Lhp

[Pax ]

.

(3)

Kp

Eqs. 1–3 all assume binding of a single paxilline molecule per
channel. The possibility that inhibition may be associated with
binding of multiple paxilline molecules will be considered in the
Results. Under various limiting conditions, some schemes become equivalent. For example, when Ep << 1 (i.e., Kp <<< Kp(o), all
three schemes are essentially identical. Furthermore, in Scheme 3,
by fixing closed-channel block to very weak binding affinity, Eq. 3
defines fractional unblock in accordance with a standard openchannel block model. The use of the H-A formulation to describe
activation is not critical for evaluating paxilline effects on the G-V
curves, as a simple Boltzmann description of activation would also
suffice. However, the H-A formulation becomes useful when simultaneously fitting inhibition by paxilline over multiple activation conditions (e.g., Figs. 6 E and 7).
For fitting of fractional inhibition by paxilline across multiple
conditions, Eqs. 1–3 were adapted in the following way. Under
different holding conditions of voltage and Ca2+, the application
of paxilline results in some defined reduction of current, reflecting equilibration of channels into nonactivatable, paxillinebound states. The test steps to positive voltages are then assumed,
for Scheme 1, to result in the opening of all channels not in
closed-paxilline–bound states. Thus, channels simply in closed
states will be activated during the brief test steps. The fraction of
unblocked channels at any condition, fun(Ca2+, V, [Pax]), is therefore defined by the ratio of Ipax/Imax at a positive test activation
418

+ Lhp

[Pax ]

,

Kp

E p [ Pax ]

Kp
,
[Pax ]
1+
Kp

(5)

or, at Ep <<< 1,

where L(hp ) is as defined above but for the equilibrium conditions
defined by the holding potential. Scheme 2, in which paxilline
does not bind to open channels, is described by Eq. 1 with Ep = 0,
such that:
1 + Lhp

Kp

Kp

Paxilline stabilizes closed states of BK channels

NPo pax NPo 0 pax =

1

[Pax ]
1+

.

(6)

Kp

Fitting of functions to various datasets was done with a Levenberg–
Marquardt nonlinear least-squares fitting algorithm implemented
within software developed within this laboratory. Error estimates
for fitted parameters represent 90% confidence limits. For all
plots, points and error bars show means ± SEM.
Chemicals. Salts and paxilline were obtained from Sigma-Aldrich.
The details of the handling of paxilline were as described previously (Zhou et al., 2010). 20-mM stock solutions of paxilline
were prepared in 100% DMSO and stored at 20°C. Paxillinecontaining physiological solutions were prepared the day of an
experiment and only used up to 4 h after preparation. [2-(trimethylammonium)ethyl] MTS bromide (MTSET), 2-aminoethyl
MTS (MTSEA), and sodium (2-sulfanoethyl) MTS (MTSES) were
obtained from Toronto Research Chemicals.

RESULTS
BK current that gates during partial inhibition by paxilline
is indistinguishable from BK current in the absence
of paxilline

Previous reports have suggested that paxilline may alter
BK G-V curves (Sanchez and McManus, 1996), although
this has not been a consistent feature of paxilline action
or that of related alkaloids (Imlach et al., 2009, 2011;
Zhou et al., 2010). A shift in the G-V curve in the presence of paxilline would suggest that part of paxilline
inhibition of BK channels arises from alteration in the
BK gating equilibrium during the time of test steps. Because of the challenges posed by slowly acting and slowly
reversible blocking drugs, we confined our comparisons to patches in which complete recovery from paxilline inhibition could be achieved. In such cases, we
observed that G-V curves generated from BK channels
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1 + Lhp +

E p [ Pax ]

with appropriate changes to accommodate Schemes 2 and 3. For
measurement of NPo at a fixed holding potential, only channels
in O and paxilline-bound–open states (Op) would contribute to Po.
At the limit of very low Po,

E p [ Pax ]
Kp

1 + Lhp +

E p [ Pax ]
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paxilline results in slow diminution of BK current with a time constant (fitted red line) of 9.6 ± 1.1 s. (F) For the same patches as
in E, steps to 160 mV with 300 µM Ca2+ were used to monitor
recovery from paxilline inhibition, with recovery at 300 µM Ca2+
at 80 mV with the indicated recovery time constant (red line).
(G) For a single patch, BK current activation (closed circles) was
monitored at 160 mV and deactivation (open circles) at 80 mV
with 300 µM Ca2+ before and during the application of 20 nM paxilline, showing that paxilline does not alter the kinetics of channels that open and close in the presence of paxilline. (H) A patch
was held at 0 mV and 500 nM paxilline was applied at either of
two different Ca2+ concentrations (10 or 100 µM). The onset of
paxilline block is more rapid with 10 µM Ca2+.
Zhou and Lingle
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Channels that activate in the presence of paxilline gate
with normal voltage dependence and kinetics. (A) G-V curves
were normalized to the maximal conductance observed in control saline. Currents were activated with 10 µM cytosolic Ca2+ from
a holding potential of 0 mV. For prepaxilline, Vh = 16.31 ± 0.15 mV
(z = 0.87 ± 0.01 e); in 100 nM paxilline, Vh = 24.75 ± 0.13 mV
(z = 0.86 ± 0.01 e); and, after washout of paxilline, Vh = 28.0 ±
0.19 mV (z = 0.88 ± 0.01 e). (B) G-V curves from A were normalized
to the fitted maximum for each condition to highlight the lack of
G-V shift. (C) G-V curves were generated in the presence and absence of paxilline, but with all solutions containing 10 mM DTT
(n = 7 patches). For control saline, Vh = 25.04 ± 1.2 mV (z = 0.86 ±
0.06 e); with 50 nM paxilline, Vh = 21.21 ± 1.85 (z = 0.79 ± 0.07 e);
and after wash, Vh = 28.65 ± 9.0 (z =1.13 ± 0.05 e). (D) The same
G-V curves in C are normalized to the maximal conductance in
each case to highlight their similarity. (E) 2-ms steps to 160 mV
were applied at 0.2 Hz to monitor BK activation with 300 µM Ca2+,
while holding the patch at 80 mV. The application of 100 nM
Figure 1.

in inside-out patches studied with symmetrical K+ solutions exhibit no clear shift in the voltage of half-activation during applications of paxilline at concentrations
producing >50% inhibition (Fig. 1, A and B). Because
of concern that slow gating shifts, perhaps redox dependent (DiChiara and Reinhart, 1997), might appear to
underlie a change during prolonged paxilline application, we also examined the effect of paxilline on G-V
curves in the constant presence of dithiothreitol (Fig. 1,
C and D) without observing any effect. Thus, those BK
channels that are activated during brief activation steps
in the presence of paxilline appear to open and close
with normal voltage and Ca2+ dependence. In the Discussion, we point out reasons why apparent shifts in G-V
curves might be observed under some conditions based
on the features of the paxilline inhibitory mechanism
described here.
During the wash-in and wash-out of paxilline, both
inhibition (Fig. 1 E) and removal of inhibition (Fig. 1 F)
develop over tens of seconds, despite the use of a solution exchange system in which blockade and recovery
from inhibition by quaternary ammonium blockers is
complete within a few seconds or hundreds of milliseconds (e.g., see Fig. 12). Although it is possible that a
slow equilibration of the paxilline concentration at the
site of inhibition may contribute to the slow kinetics, it
seems likely that the molecular steps involved in the development and recovery from paxilline inhibition are
themselves slow (as will be addressed further below).
Under such a situation, once a particular blocking equilibrium is established at a given holding condition, brief
changes in membrane potential (as in the generation of
a G-V curve) would not be expected to appreciably alter
the overall block equilibrium. Therefore, although paxilline inhibition does depend inversely on channel Po
(see below), under all conditions both the onset and
recovery from paxilline inhibition is sufficiently slow,
such that brief depolarizations of a few tens of milliseconds will not alter the paxilline block equilibrium established at a given holding condition. As an additional
evaluation of the properties of channels activated in the
presence of paxilline, we compared the activation and
deactivation time course of BK currents in the absence
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Inhibition by paxilline varies inversely with steady-state
channel Po at the equilibrium condition

To explore further the dependence of paxilline inhibition on Ca2+, we examined the fractional block produced

by paxilline on BK channels held under three different equilibration conditions differing in Po: (1) 0 mV,
10 µM Ca2+ (Po of 0.02); (2) 70 mV, 300 µM Ca2+
(Po of 0.07); (3) 0 mV, 300 µM Ca2+ (Po of 0.48).
G-V curves were generated for each equilibration condition for control solutions and in both 10 and 100 nM
paxilline. For this set of patches, each patch was examined under all three conditions. In each case, paxilline
was applied for 4 min to allow equilibration before
generation of curves. Recovery from any individual application of paxilline was at least 90%. For the condition of lowest resting Po (Po of <0.02; 0 mV, 10 µM
Ca2+), 10 nM paxilline blocked over half the current
activated at each voltage, whereas 100 nM paxilline
produced essentially complete inhibition (Fig. 2 A).
Changing the equilibration condition to 300 µM Ca2+
at 0 mV (Po of 0.48; Fig. 2 B) resulted in a marked
reduction in the effectiveness of paxilline inhibition at
both 10 and 100 nM, consistent with the idea that elevation of [Ca2+] diminishes paxilline block. However,
when the equilibration condition was changed to 70 mV
with 300 µM Ca2+ (Po of 0.07; Fig. 2 C), paxilline inhibition returned to levels more similar to those obtained with 10 µM Ca2+ at 0 mV (Fig. 2 A). These results
suggest that inhibition by paxilline may not be reduced
by increases in Ca2+ per se, but by increases in channel
Po. Specifically, paxilline inhibition is inversely related
to the BK channel Po at the equilibration condition
under which paxilline is applied (Fig. 2 D). This inverse
relationship between BK Po and inhibition by paxilline immediately excludes the simple case that paxilline exclusively blocks open channels.

Block by paxilline exhibits an inverse dependence on Po, but no dependence on Ca2+ per se. G-V
curves were generated under three equilibration conditions (A: 10 µM Ca2+, 0 mV; B: 300 µM Ca2+, 0 mV;
C: 300 µM, 70 mV), with either control saline or either
of two paxilline concentrations, 10 or 100 nM. For all
patches included in this dataset, each patch was examined under all conditions. Paxilline was applied for
4 min before generation of G-V curves. Among different patches, the sequence of holding conditions was
varied. G-V curves were normalized to the maximal conductance observed in the absence of paxilline under
each holding condition. Curves to control points are
fitted single Boltzmann functions, whereas curves in
the presence of paxilline have no significance. (D) The
fractional block for voltages from 40 to 120 mV was determined for each paxilline application under the three
conditions and plotted in relation to the Po at the holding
condition defined by the fitted Boltzmann. For 10 µM
Ca2+ and 0 mV, the effective Po was 0.02; for 300 µM
and 70 mV, the Po was 0.07; and for 300 µM Ca2+ and
0 mV, the Po at the holding condition was 0.48.
Figure 2.
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of paxilline and during development of inhibition by
paxilline (Fig. 1 G). As inhibition by paxilline develops,
neither the activation nor deactivation time constant
is altered.
Collectively, these initial tests establish a few features
of paxilline inhibition critical to evaluation of later experiments. First, the results show that the BK current
that persists during partial inhibition by paxilline gate
normally. Second, these results are consistent with the
suggestion (Zhou et al., 2010) that the fractional inhibition by paxilline reflects inhibition established at the
holding condition or equilibration conditions of the
experiment (i.e., voltage and Ca2+). Channels inhibited
by paxilline simply do not contribute to the observed
currents, and brief depolarizing steps do not result in
changes in the paxilline block equilibrium.
Prompted by earlier results (Sanchez and McManus,
1996) indicating that inhibition of BK channels by paxilline is reduced by elevations in Ca2+, we also examined
the onset and/or recovery of paxilline inhibition with
either 10 or 100 µM Ca2+ while holding a patch at 0 mV.
The onset of block by 500 nM paxilline was faster and
recovery was slower with 10 µM Ca2+ compared with
100 µM Ca2+ (Fig. 1 H), qualitatively consistent with
the earlier observations (Sanchez and McManus, 1996).
This result prompted a more detailed examination of
the conditions that influence paxilline inhibition pre
sented below.
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The weak inhibition by paxilline of BK currents held
at positive holding potentials with elevated Ca2+ was also
tested in a set of patches in which only a single BK channel was expressed. Patches were held either at 70 or
70 mV with 300 µM Ca2+. In one such patch (Fig. 3 D),
after the establishment of a given equilibration condition (>45 s), channel activity was monitored first with a
500-msec period at 70 mV and then a 500-msec period
at 70 mV, separated by 50 ms at 0 mV (Fig. 3 D, 1). After
development of inhibition by 100 nM paxilline at 70 mV,
subsequent test steps show essentially no channel activation at either 70 or 70 mV (Fig. 3 D, 2). After return
to a holding potential of 70 mV while still in the presence of 100 nM paxilline, channel activity similar to the
control behavior was restored at both 70 and 70 mV
(Fig. 3 D, 3). Thus, even in the constant presence of
paxilline, channels can recover from inhibition at conditions of high Po. After returning the holding potential to 70 mV (while still in the presence of paxilline),
complete inhibition was reestablished (Fig. 3 D, 4). Finally, after washout of paxilline while holding at 70 mV,
channel activity was restored (Fig. 3 D, 5). Subsequent
wash-in of paxilline while holding at 70 mV failed to

Figure 3. Paxilline inhibits channels at conditions of low Po, but
not under conditions of high Po.
(A) An inside-out patch bathed
with 300 µM Ca2+ was initially held
at 80 mV. The patch potential was
then stepped to holding potentials
of 40, 0, 40, and 80 mV (from left
to right), and 1.6-ms steps to 160 mV
were used to monitor available BK
current, while 100 nM paxilline was
applied after the 10th step at a
given holding potential. Paxilline
was washed out and full recovery
from block was obtained between
tests at different holding potentials.
At the most negative potentials,
block is substantial, whereas at 40
and 0 mV, there is little development of block. (B) The peak outward current from the traces in A
is plotted as a function of elapsed
experimental time. (C) The time
course of reduction of current
during sustained depolarization to
80 mV is shown, establishing that
the reduction of current at the positive holding potentials (B) does
not reflect paxilline block, but an
intrinsic slow reduction in BK conductance with prolonged depolarization. (D) All traces are from the
same single-channel patch, stimulated with the protocol shown on the top. The patch was constantly exposed to 300 µM cytosolic Ca2+.
(1) Control activity in the absence of paxilline. (2) The holding potential was changed to 70 mV, and 100 nM paxilline was applied.
The trace was taken after 30 s in paxilline. (3) The trace was taken 30 s after the patch had been returned to 70 mV while in the
constant presence of 100 nM paxilline. (4) The trace was taken 30 s after the patch was again returned to 70 mV while in paxilline.
(5) The trace was obtained after washout of paxilline while holding the patch at 70 mV. (6) The trace was taken 30 s after 100 nM
paxilline was applied while holding at 70 mV.
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We next examined the inhibition produced by 100 nM
paxilline over holding potentials from 80 to 80 mV
with constant 300 µM Ca2+, with unblocked current monitored by brief depolarizing steps to 160 mV (Fig. 3 A).
Paxilline was washed out between tests at different holding potentials. At holding potentials of 80 and 40 mV,
the application of 100 nM paxilline resulted in a
similar onset and extent of inhibition (Fig. 3 B). At 0 mV,
paxilline inhibition was slower and incomplete, whereas
at 80 mV, paxilline produced almost no inhibition over
1 min of application. At the most positive holding potentials in this experiment (40 and 80 mV), the steadystate conductance activated by steps to 160 mV was
reduced relative to that at more negative holding potentials. This reflects a very slow inactivation behavior
often observed for BK channels activated with strong
depolarizations and elevated Ca2+ (Fig. 3 C), and does
not appear to be related to paxilline inhibition. Overall,
this result further supports the view that paxilline block
is markedly reduced under conditions favoring open
BK channels, whether from elevations in Ca2+ or depolarization. Remarkably, paxilline has almost no inhibitory effect under conditions near maximal BK Po.

Published October 27, 2014

that paxilline alters the C-O equilibrium, in essence reducing the equilibrium constant, L. Patches with a large
number of channels were therefore used to obtain estimates of NPo at 80 mV, both at 10 and 300 µM Ca2+
(for 300 µM Ca2+, see Fig. 5 A) alone and then with different paxilline concentrations. The NPo in the presence of paxilline was then normalized to the NPo
measured for that patch in the absence of paxilline
(Fig. 5 B). Paxilline inhibited the BK current by >95%
at 100 nM paxilline, both in 10 and 300 µM Ca2+. Because the results above suggest that the effects of paxilline on open states are minimal, the reduction of NPo
at negative potentials suggests that paxilline markedly
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restore inhibition (Fig. 3 D, 6). It is noteworthy that
during inhibition by paxilline, no openings are observed
at all during these brief 500-ms periods at either 70 or
70 mV (Fig. 3 D, 2 and 4). Thus, several 100 ms are not
sufficient to allow recovery from paxilline inhibition,
even at conditions favoring high Po. However, when the
test sequence is applied after equilibration in paxilline
at 70 mV, BK openings still occur intermittently during
the entire 500 ms at 70 mV (Fig. 3 D, 3). This is generally consistent with the earlier results (Fig. 1 E), indicating that the onset of paxilline inhibition develops over
several seconds.
The ability of inhibition by paxilline to be reversed
by changes in equilibration conditions, even in the
constant presence of paxilline, was also confirmed in
patches with large numbers of BK channels (Fig. 4).
Specifically, after onset of block in 100 nM paxilline
(Fig. 4 A), changing the equilibration conditions to
those favoring unblocking can produce recovery from
paxilline inhibition (Fig. 4, B and C). It may be noticed
that the onset of paxilline inhibition appears variable
during wash-in of paxilline. This is addressed below and
appears to reflect variability in paxilline access to the
patch, despite the rapidity of solution exchange with small
charged molecules.
These tests show clearly that inhibition of BK channels
by paxilline is reduced or even absent under conditions favoring high Po, whether produced by depolari
zation or by Ca2+. Qualitatively, the relief of inhibition
at high Po suggests either that: (a) if paxilline binds
with nanomolar affinity to the open state, it must not
occlude permeation; or (b) if paxilline can occlude permeation, it must only bind very weakly to the open state.
Most importantly, it suggests that effects on the open
state are not central to inhibition by paxilline.
Paxilline inhibits BK NPo under conditions where voltage
sensors are largely inactive

Paxilline might favor occupancy of channels in closed
states, perhaps without directly occluding the ion permeation pathway, by a variety of mechanisms. In one,
the binding of paxilline may alter the C-O equilibrium
constant, L, favoring occupancy of closed states. In another, paxilline may stabilize the BK voltage sensors in
resting states. A third possibility, that paxilline disrupts
the linkage of Ca2+ binding to gating, seems unlikely, as
increases in Ca2+ reduce paxilline inhibition.
At negative potentials where voltage sensors are largely
inactive, BK channels open at low Po, even in the absence of Ca2+ in accordance with the intrinsic equilibrium (L) between unliganded closed and unliganded
open channels (Horrigan and Aldrich, 2002). Under
such conditions, increases in cytosolic Ca2+ favor additional BK channel activation (Horrigan and Aldrich,
2002). If paxilline is able to reduce NPo when voltage
sensors are largely inactive, it would support the possibility
422
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Figure 4. Essentially complete recovery from paxilline block can
occur, even in the continuous presence of paxilline under conditions of high Po. (A) The indicated test-pulse sequence was applied every 1 s while holding at 80 mV with 300 µM Ca2+. The
traces show before paxilline application, after 50% inhibition
by paxilline, and during the full paxilline effect. (B) For the same
patch in A, the equilibration conditions were altered to 80 mV
with 300 µM Ca2+ while still in the continuous presence of 100 nM
paxilline. Brief sojourns to 80 mV with test steps to 160 mV were
used to monitor recovery in the presence of paxilline. A 60-s washout of paxilline confirmed that no additional recovery occurred.
(C) The time course of onset and recovery from inhibition by
100 nM paxilline, while in the continuous presence of paxilline,
is plotted for the cell shown in A and B, with the numbers corresponding to the approximate times of the traces in A and B.
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increases the fraction of time a channel is closed. A fit
of a simple Hill function (see legend to Fig. 5) to the
paxilline-induced reduction in normalized NPo yielded
an IC50 for inhibition of 5.0 ± 1.5 nM with n = 0.85 ±
0.25, with n = 1 clearly better than n = 2 (Fig. 5 B). This

NPo ( pax ) NPo =

1
n

 [ PAX ] 
1+ 

 IC 50 

,

with IC50 = 5.5 ± 1.1 nM with n = 1. Red dotted line corresponds to
a fit of the same function with n = 2. (C) Gating currents measured with an activation step to 160 mV from 80 mV with 0 µM
Ca2+ are shown in the absence and presence of 500 nM paxilline.
(D) The Qon integrated over 1 ms for steps to the indicated potentials are plotted for control and 500-nM paxilline solutions. Fitted
lines correspond to: without paxilline, z = 0.56 ± 0.050 e with Vh =
137.6 ± 14.3 mV; with paxilline, z = 0.54 ± 0.025 e with Vh = 131.4 ±
2.1 mV. (E) Qoff is plotted as a function of previous command
potential for 0 and 500 nM paxilline. Without paxilline, z = 0.66 ±
0.07 e with Vh = 142.7 ± 14.3 mV; with paxilline, z = 0.56 ± 0.035 e
with Vh = 130.2 ± 9.1 mV.


Inhibition of BK current is best explained by binding
to and stabilization of closed states

100 nM paxilline reduced the normalized NPo to <0.05
at 80 mV and 300 µM Ca2+. This is consistent with
a mechanism in which binding of paxilline reduces
the intrinsic O/C ratio by >0.05, favoring occupancy of
closed channels. However, the data do not distinguish
among different models of block involving closedchannel stabilization. The recognition that unblock
from paxilline can be facilitated by high Po conditions
prompted us to pursue a more extensive examination
of the paxilline concentration dependence under different equilibration conditions. We therefore examined
the concentration dependence of paxilline inhibition
over a range of equilibration conditions that span a
wide range of BK Po. Specifically, paxilline inhibition
was examined with equilibration conditions of 300 µM
Ca2+ at 70 mV (Fig. 6, A and C), 0 mV, 40 mV (Fig. 6,
B and D), and 70 mV. For the set of patches used in
this experiment, these equilibration conditions corresponded to effective Po’s of 0.1, 0.65, 0.83, and
0.89. For each equilibration condition, fractional inhibition was determined for at least four different paxilline concentrations (Fig. 6, A–D). To monitor block
under each of these conditions, brief 2-ms test steps to
Zhou and Lingle
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Paxilline reduces NPo at conditions where voltage sensors are largely inactive, and does not influence the voltage-sensor
equilibrium. (A; top) The trace shows example channel activity at
80 mV and 300 µM Ca2+ for a macropatch with many channels.
4-ms steps to 100 mV (not depicted) were also used to monitor
paxilline inhibition. (Middle and bottom) These traces show activity under the same conditions but with 5 and 100 nM paxilline,
respectively. NPo was determined from activity at 80 mV.
(B) The NPo measured in paxilline for 3 s of activity normalized
by the NPo measured in the absence of paxilline is plotted as a
function of paxilline. The solid line corresponds to a fit of

Figure 5.

result indicates that the binding of paxilline produces a
>95% inhibition of BK Po under conditions in which
voltage sensors are largely inactive and Po is defined
largely by the intrinsic C-O equilibrium.
To evaluate whether the effects of paxilline are independent of any effect on voltage sensors, we measured
gating currents in patches containing large numbers of
channels, both in the absence and then in the presence of 500 nM paxilline (Fig. 5 C). The gating current
associated with activation steps (Qon) was determined
over a range of activation voltages and normalized to
the fitted Qon(max) defined from a simple Boltzmann
(Fig. 5 D). The Qon versus command potential relationship was essentially identical in the absence and presence of 500 nM paxilline. Qoff was also determined
in the presence and absence of paxilline (Fig. 5 E).
Although any effect of paxilline on Qoff is small, the
duration of the activation step preceding the off-step is
likely to have been sufficient to have caused some channels to open in the absence of paxilline, while less
likely to have opened in the presence of paxilline. Thus,
the Qoff relationship in paxilline likely reflects solely
equilibration of voltage sensors among closed states,
whereas in the absence of paxilline, there may be contributions of voltage sensors, as some channels pass
from open to closed states. Regardless of the origins of
the slight difference observed in Qoff, the results provide strong support for the idea that paxilline does not
alter the voltage-sensor equilibrium nor impede voltagesensor movement.
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160 were used, which do not alter the fraction of channels blocked by paxilline. Current activated by the brief
test steps corresponds to that fraction of channels in all
unblocked states at the equilibration conditions. For
paxilline application under conditions of highest Po
(either 40 or 80 mV at 300 µM Ca2+), the slow onset of
inhibition posed challenges to a direct determination
of steady-state inhibition. In such cases, a fit of a single
exponential to the onset of block (Fig. 6 D) was used to
obtain an extrapolated estimate of fractional inhibition. Furthermore, despite the ability of high Po to reduce inhibition by paxilline, at the highest paxilline
concentrations full wash-out was difficult to achieve,
perhaps because of accumulation of paxilline within
the recording pipette during the long durations of

paxilline application. To minimize uncertainties arising from cumulative inhibition, at the highest Po condition patches were only used for one to two paxilline
applications (e.g., Fig. 6, B and D). Consistent with
earlier experiments, the concentrations of paxilline
required to produce inhibition at conditions of high
Po were orders of magnitude higher than those required at lowest Po.
From this type of experiment, the fractional inhi
bition by paxilline shifts markedly rightward as the
equilibration conditions result in channels of higher Po
(Fig. 6 E). If one fits a simple Hill equation through the
plot of fractional unblock as a function of [paxilline]
under each equilibration condition (Fig. 6 E, red dotted lines), the apparent IC50 for paxilline inhibition
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Concentration dependence of paxilline
inhibition at four different conditions of channel
Po. (A) Traces show currents activated by brief steps
to 160 mV under equilibration conditions of 70 mV
and 300 µM Ca2+ with 5, 20, 50, and 200 nM paxilline. Red line shows the identical level of peak current for each paxilline test. (B) Traces show currents
activated by steps to 160 mV under equilibration
conditions of 40 mV and 300 µM Ca2+ for 200 nM,
500 nM, and 5 µM paxilline, all from the same patch.
(C) The onset of inhibition of current activated at
160 mV with 300 µM Ca2+ at 70-mV equilibration
condition from traces as in A is shown for five paxilline concentrations along with single-exponential
fits (red). (D) Onset of inhibition with single-exponential fits (red) is shown for the higher Po equilibrium condition (B). (E) The fraction of unblocked
BK current is plotted as a function of paxilline for
four different equilibration conditions (70, 0, 40,
and 70 mV, all with 300 µM Ca2+) from experiments
as in A and B. Dotted red lines correspond to fits of a
Hill function, with IC50 values of 11.7 ± 1.9 nM, 58.4 ±
2.9 nM, 469.8 ± 94.9 nM, and 5.37 ± 1.0 µM, from left
to right. Solid lines correspond to the fit of Scheme 1,
with Kp = 11.85 nM and Ep = 0.002, with n = 1.09.
(F) The inhibition of NPo at 80 mV and either 10
or 300 µM Ca2+ is displayed from Fig. 5 B, with the
dotted red line corresponding to the best fit from
Scheme 1 (E) (Kp = 11.85 nM). (G) IC50s from E are
plotted as a function of O/C and fit with log(IC50) =
m(O/C) + log(Kcp), where m (0.33 ± 0.02) is the
slope of the relationship and Kp (12.1 ± 1.1 nM) is
the extrapolated IC50 with all channels closed. This
provides a model-independent estimate of paxilline
inhibition of closed channels. (H) IC50 estimates are
replotted as a function of Po along with the fit in F.
The extrapolation of the line to Po of 1 provides a
model-independent estimate of paxilline inhibition
of open channels.
Figure 6.
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shifts from 11.7 nM, 58.4 nM, 469.8 nM, to 5.3 µM over
the equilibration conditions of 70, 0, 40, and 70 mV
all at 300 µM Ca2+. This provides additional strong support for the unusual state dependence of paxilline in
hibition, with inhibition being much more strongly
favored under conditions of low Po. If we assume that
the effect of paxilline arises solely from an alteration
in the C-O equilibrium constant, L(0) as defined in
Scheme 1, a fit of this model (Eq. 1) yields Kp = 11.9 ±
2.3 nM, with n = 1.09 ± 0.11 and Ep of 0.002 (Fig. 6 E,
black lines). This dataset and model imply that the binding of paxilline to the open channel is 500-fold weaker
than the binding to closed channels, and that a single

paxilline molecule produces the inhibitory effect. This
model also assumes that the binding of paxilline to the
open state does not block conductance. An interesting
feature of this model is the tendency toward flattening of
the predicted block curves at <100% block at the highest
paxilline concentrations. Although this estimate of Kp is
somewhat greater than estimated in the measurements
of paxilline inhibition under conditions of inactive voltage sensors (Fig. 5, A–C), the fitted value of Scheme 1 for
the low Po situation provides a satisfactory approximation of the reductions of NPo (Fig. 6 F). The suitability of
this model and other models will be addressed in more
detail below.
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Paxilline stabilizes closed states with only weak, if any, binding to open states. (A) Curves of concentration-dependent inhibition of BK current at four equilibration conditions were fit with Scheme 1, with the assumption that the current activated at positive
potentials reflects channels initially either in C, O, or OB, i.e., any open channels with bound paxilline are conducting. Each panel
from left to right corresponds to fits with Scheme 1 (Eq. 7) in which either one, two, or four paxilline molecules can bind to inhibitory
positions. Best-fit values are given in the figure. The model with n = 1 best accounts for the shape of the inhibition by paxilline. (B; left)
Scheme 1 was again used, while constraining Ep to 0.01 (left), 0.1 (middle), or 1.0 (right), showing that increasing open-state affinity
fails to account for the data. Right-hand panel corresponds to state-independent paxilline interaction with C and O. (C) Ep was set to 0,
thereby approximating strictly closed-channel block. (D) Data were fit with Scheme 3 (Eq. 3) in which the paxilline-bound open state
is nonconducting. On the left, the value for Ep drifted toward 0, similar to a strictly closed-channel block situation. On the right, Ep was
set to 1 (state-independent binding of paxilline). SSQN in A and C corresponds to the sum-of-squares for a given fit normalized to the
sum-of-squares for the left panel in A.
Figure 7.
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Allosteric regulation of the C-O equilibrium constant, L,
best explains paxilline action

Although Scheme 1 yielded a very satisfactory fit of the
reduction of current as a function of paxilline, we next
assessed whether other variations of Scheme 1 or other
schemes that include closed-channel block would also be
consistent with the data. First, we compared the extent to
which the quality of the fit with Scheme 1 was dependent
on whether one, two, or four paxilline molecules could
all occupy inhibitory positions. Eq. 1 was modified (Eq. 7)
to reflect up to n paxilline-binding sites, where each site
independently influences the C-O equilibrium. This is
analogous to the regulation of L by Ca2+ (Horrigan and
Aldrich, 2002), except that instead of increasing BK activation, activation is inhibited.
n


E p [ Pax ] 
Lhp +  1 +


K p 

.
f un ( Pax , hp ) =
n
n

 [ Pax ] 
E p [ Pax ] 
 + Lhp  1 +

1 +


K p 
K p 



(7)

When paxilline inhibition is assumed to involve two
or four independent sites, the resulting fits do a less adequate job of approximating the data compared with a
single paxilline-binding site (Fig. 7 A). This therefore
suggests that, wherever the site of paxilline action within
the BK tetramer, a channel can probably only accommodate a single paxilline molecule.
Both the model-independent analysis in Fig. 6 and
the fit of Scheme 1 to the concentration dependence of
paxilline inhibition (Fig. 7 A) indicate a nearly 1,000fold difference between paxilline affinity between closed
and open states. We next compared the consequence of
assuming a smaller difference in affinity (Ep = 0.01, 0.1, or
1) in Scheme 1 (Fig. 7 B). Even with a 100-fold difference
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in closed- and open-state affinity (Ep = 0.01), the resulting fit is completely inadequate, again supporting the
view that paxilline exerts a very strong effect on the C-O
equilibrium. The case in which Ep = 1 (Fig. 7 B, right)
corresponds to a completely state-independent form of
Scheme 1. In this case, inhibition is absent for the
higher Po conditions, even at maximal [paxilline], as
both O and Op are conducting states.
Do the results permit us to exclude other models?
The value of Ep estimated from the fit of Scheme 1 immediately suggests that the dataset is unlikely to strongly
distinguish among the different models. To evaluate
this directly, we first fit the paxilline concentration dependence of inhibition with Scheme 2 (Fig. 7 C; closedstate inhibition alone; Eq. 2). This results in an adequate
fit of the data, although not as good as with Scheme 1.
With Scheme 3 (both closed and open states can be
inhibited by paxilline; Eq. 3), convergence was only
achieved when Ep was set to very small values, essentially
making it identical to closed-channel block (Fig. 7 D).
A state-independent form (Ep = 1) of Scheme 3 illustrates
that, under all conditions of Po, inhibition by paxilline
would be identical.
These results strongly support the idea that the binding of a paxilline molecule to a BK channel strongly
stabilizes closed states, corresponding to a >500-fold
reduction in the C-O equilibrium constant, L(0). Furthermore, the analysis suggests that only one paxilline
molecule can act on a BK channel at a time. Can we
exclude the possibility that paxilline does not bind to
open channels at all? Thermodynamically, that is unlikely. Although the optimal fit was achieved for Scheme 1,
the differences among Fig. 7 A (left), Fig. 7 C, and
Fig. 7 D arise largely from the data points at 300 µM
Ca2+, 70 mV, at the highest paxilline concentrations.
Both Schemes 2 and 3 predict stronger block and essentially complete block at the highest concentrations,
whereas Scheme 1 predicts some finite current at the
highest paxilline concentrations, as open paxillinebound channels are conducting. Unfortunately, it is the
estimates of fractional inhibition at 5 and 20 µM paxilline that are the most technically challenging and probably most subject to errors, as fractional block was often
estimated from extrapolation of a fitted exponential.
Yet, despite this uncertainty, the key point is that paxilline affinity between closed and open states differs
markedly. In fact, for all practical purposes, for conditions under which paxilline is typically used to inhibit
BK channels, only closed-channel binding and stabilization are relevant.
Kinetics of onset of paxilline inhibition

An examination of the kinetics of the onset and recovery from paxilline inhibition and dependence on paxilline concentration may help provide additional insight
into mechanism. However, as noted in regards to Fig. 1 E,
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Another way of viewing the inhibition by paxilline is to
plot the nominal IC50 (estimated from the fit of NPo(pax)/
NPo(max) = 1/(1 + [PAX]/IC50) relative to state occupancy. Specifically, a plot of IC50 versus Po/(1  Po)
(Fig. 6 G) provides some largely model-independent
conclusions about paxilline action. Empirically, log(IC50)
varies linearly with Po/(1  Po) over a broad range of
closed-state occupancies. At the limit of maximal C-state
occupancy, for this set of data the limiting IC50 is 12.1 ±
1.1 nM, which essentially provides a model-independent
estimate of the closed-state affinity for paxilline (Fig. 6 G).
As C-state occupancy decreases, IC50 changes almost
1,000-fold, implying that if paxilline binds to and inhibits
open states, it must do so at an affinity almost 1,000-fold
weaker than binding to the closed states. The lack of
horizontal asymptote in the relationship between IC50 as
a function of Po (Fig. 6 H) also strongly suggests that the
open state is not directly inhibited at concentrations up
to 10 µM.
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we observed that, despite identical conditions of Po, stimulation, and paxilline concentrations (compare Figs. 1,
G–H, 3 B, 4 C, and 8 A), the apparent onset of inhibition, when paxilline is washed onto a patch, appeared
to vary substantially from patch to patch. However, with
the realization that the paxilline-blocking equilibrium
can be simply shifted from blocked to unblocked by
changes in patch equilibrium conditions, we wondered
whether consistent estimates of block onset and recovery could be obtained by shifts in the equilibration conditions while maintaining patches in the continuous
presence of paxilline.
As a first step, we compared the apparent onset of
paxilline inhibition both from direct wash-in of paxilline
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Kinetics of block onset is more reliably estimated by
step changes in equilibration conditions while in the constant
presence of paxilline rather than by wash-in of paxilline. (A) On
set of paxilline is compared at 80 mV and 300 µM Ca2+ for two
situations: first, simple perfusion of 100 nM paxilline over the
cytosolic face of the face, and second, a change in equilibration
conditions from 80 to 80 mV. Voltage protocols in each case
are shown schematically. Available BK current was monitored by
a 2-ms step to 160 mV applied at 0.5 Hz. Symbols over the voltage steps for a particular protocol correspond to the particular
symbols showing the onset of block as a function of elapsed time,
with single-exponential time constants as given. (B) Estimates of
time constants from individual patches for each method of assessing paxilline block are shown along with means and STD. Each
method was evaluated with the same patches. An F-test provided
an assessment of whether variance for each set of estimates was
significantly different.

Figure 8.

and also from changes in equilibration conditions in
the same set of patches (Fig. 8). For this set of four
patches, the onset of inhibition by simple wash-in of
100 nM paxilline at 80 mV with 300 µM Ca2+ occurred
with a time constant of on of 26.3 ± 6.6 s (mean ± STD).
In contrast, after establishing a steady-state unblocked
(Fig. 8 A; 80 mV; 100 nM paxilline) condition, the holding potential was changed to promote block (Fig. 8 A;
80 mV). In this case, the onset of paxilline inhibition
(80 mV, 300 µM Ca2+) developed with a time constant
of 6.85 ± 1.79 s, about fourfold faster than that observed
with paxilline wash-in (Fig. 8 A). The variance of estimates obtained from paxilline wash-in was significantly
greater (F-test) than that from estimates derived from
changes in equilibration conditions. Although our solution-exchange system generally allows for complete
exchange of readily soluble molecules within a few hundred milliseconds (e.g., Fig. 14 A), we suspect that the
slow onset of paxilline inhibition during wash-in may be
influenced by a slow increase in paxilline concentration
within the omega of the inside-out patch, given the tendency of paxilline to stick to or partition into any available hydrophobic surface–including membranes.
The variability and slower onset of inhibition that
occurs with direct paxilline perfusion suggests that
wash-in is not a useful method for assessing kinetic aspects
of paxilline inhibition. However, the kinetics of block
onset, while in the continuous presence of paxilline, is
likely to represent some intrinsic kinetic step in the paxilline inhibitory equilibrium. We therefore measured
the onset of paxilline inhibition under a more extensive
set of conditions. First, after equilibration with 100 nM
paxilline at 80 mV and 300 µM Ca2+, during which no
inhibition was observed, we then examined the onset of
paxilline inhibition at potentials from 20 mV to 60 mV
(Fig. 9, A and B), using a protocol identical to that used
in Fig. 8 A. The rate of inhibition varied over 20-fold
from 20 to 60 mV (Fig. 9, B and D). The onset of inhibition was reasonably well fit with a single-exponential
function, but at some conditions of intermediate closed
probability (Pc), a double-exponential function yielded
a clearly superior fit (Fig. 9 C), with the resulting sumof-squares improved four- to fivefold. The rate of block
was plotted as a function of Pc, the probability of being
closed, using the mean rate from fits of the single exponential using the faster rate when a two exponential
better described the time course. The rate of inhibition
is clearly faster when channels are primarily closed
(Fig. 9 D). However, using exclusively the rate obtained
from the single-exponential fit, the relationship exhibits a superlinearity that does not follow immediately
from the idea that the rate of block depends exclusively
on Pc. For a simple two-state gating scheme where opening and closing rates are at rapid equilibrium compared
with the microscopic block rate, the observed rate
of block might be expected to scale linearly with Pc as
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The paxilline unblocking rate is only mildly dependent
on conditions that favor increased Po

Paxilline inhibition is faster at higher closed-channel
probabilities. (A) All traces were obtained from the same patch
with the indicated voltage protocol while in the continuous
presence of 100 nM paxilline and 300 µM Ca2+. Black traces correspond to currents activated after a re-equilibration period at
80 mV (with 300 µM Ca2+), whereas red traces are the final trace
after a change to a new equilibration voltage (as indicated).
(B) The onset of current inhibition from the examples in A is
plotted as a function of time at the new equilibration potentials.
Red lines are single-exponential fits to the onset of inhibition.
(C) Onset of inhibition at intermediate Pc is better fit with two
(blue) exponential components than one (red). (D) The rate of
block (means, SEMs, and individual estimates) from experiments
as in B is plotted as a function of Pc, with Pc calculated from the
G-V curves at 300 µM Ca2+. Closed red symbols correspond to the

Figure 9.
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The rate of unblock from paxilline may also be informative regarding the blocking mechanism. In particular,
blocking Schemes 1 and 2 make very different predictions for what might be expected during a change in
equilibration conditions. In Scheme 1, closed channels
stabilized by paxilline have two potential pathways for
recovery from inhibition, one being simple unbinding
of paxilline from the closed channel, and the other
being unbinding after the channel has first undergone

faster rate resulting from the fit of either one or two exponential
components to the onset time course in B and C. (E and F) Onset
of inhibition at 80 mV (E) and 100 mV (F) is shown for dif
ferent paxilline concentrations along with single-exponential fits.
(G) Blocking rate is plotted as a function of [paxilline]. The fitted
red line has a slope of 2.1 × 106 M1s1. Each dotted line connects
determinations at different [paxilline] for single patches.
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kc/(kc + ko). However, when the faster component of the
inhibition onset is used for the intermediate Pc conditions, the overall relationship between the fast onset of
block and Pc is linear, with asymptote at 0, consistent
with the idea that the initial step in block onset depends
on Pc. One potential explanation for the two exponential components is that, at the intermediate and low Pc
values, there are additional transitions, either from the
gating equilibrium or the blocking mechanism, which
contribute to the observed block onset. However, at
present, we have no simple explanation for the basis for
the two relaxation components at the intermediate
Pc values. Regardless of this uncertainty, the results
are compatible with the idea that fast components of
inhibition vary linearly with occupancy of channels in
closed states.
Next, we examined the concentration dependence of
the onset of inhibition by paxilline at 80 and 100 mV
(Fig. 9, E and F). For estimates at the highest paxilline
concentrations, the time between test steps to monitor
BK activation was reduced to 0.2 s (Fig. 9 F). Remarkably, over the range of 5 to 2,000 nM paxilline, the rate of
block was linear, with a slope of 2.1 × 106 M1s1 (Fig. 9 G).
Because these rates are measured under conditions in
which the BK channels are primarily closed, this potentially defines the rate of inhibition of a closed channel.
This pseudo–first-order molecular association rate for
paxilline interaction with a closed channel is remarkably
similar to that of uncharged anesthetics acting upon
nicotinic AChRs (Adams, 1976) and also the 0-voltage for
ward rate of inhibition of quaternary ammonium blockers
of ligand-gated channels (Neher and Steinbach, 1978;
Lingle, 1989).
Collectively, these tests of the rate of onset of inhibition by paxilline support the idea that inhibition involves
specific interaction with closed-channel conformations.
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160 mV, which by itself produces no effect on paxilline
recovery. The time course of recovery was essentially
identical for either recovery procedure, i.e., a change in
equilibration condition (black symbols in Fig. 10 A) or
washout of paxilline (red symbols in Fig. 10 A). The
time constant of recovery was about twofold briefer at
80 mV compared with 0 mV. At more negative voltages
corresponding to conditions of lower Po, the fractional
unblock resulting from a change in equilibration conditions precluded careful delineation of the recovery time
course. However, the correspondence of the time constants measured either from washout or the change
in equilibration allowed simple washout of paxilline to
be used to define unblock at conditions of lower Po
(Fig. 10 B). For another patch, after the development of
inhibition by three separate applications of 100 nM paxilline at 80 mV with 300 µM Ca2+, recovery from inhibition was monitored at 80, 40, and 0 mV (Fig. 10 B),

Figure 10. Recovery from paxilline inhibition is
faster at higher Po. (A) Unblock time constant from
washout of paxilline is comparable to unblock during change in equilibration conditions. The panels
are all from the same patch, with the unblocking
time course examined at 0 (top), 40 (middle), or
80 mV (bottom). Black symbols and fitted line correspond to unblock in the constant presence of 100 nM
paxilline after a change in equilibration condition
from 80 mV, 300 µM Ca2+ to each of the three voltages. Red symbols and fitted red lines correspond to
washout of paxilline at the indicated voltage with
300 µM Ca2+. BK availability was assessed with brief
test steps to 160 mV. Po during the recovery conditions was estimated from G-V curves as 0.7 (0 mV,
top), 0.85 (40 mV, middle), and 0.9 (80 mV,
bottom). (B) Recovery time course was compared in
the same patch for washout of paxilline at 0 (Po of
0.7), 40 (Po of 0.4), and 80 mV (Po of 0.1),
all in 300 µM Ca2+. (C) Recovery time course from A
(middle) for washout of paxilline is plotted on a
logarithmic scale along with fits of an exponential
of form I(t) = (1  exp(t/tau)n, for n = 1, 2, or 4.
(D) Open circles show recovery time constants for
patches examined as in A, with closed symbols corresponding to time constants measured during paxilline washout, and open circles corresponding to
the constant presence of paxilline, with each point
reflecting the mean of at least four patches. Closed
diamonds correspond to time constants measured
as in B. The fitted G-V curve (Vh = 34.0 mV; z =
0.98) for currents activated in the patches in A and
B is shown to highlight the extent of changes in
fractional activation for the different recovery conditions. Red symbols correspond to seven patches
for which recovery was measured at 0 mV in the
constant presence of either 100 nM paxilline (red
square) or 20 nM paxilline (red circle).
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a closed to open conformational change. For Scheme 2,
unblock can only occur from the closed state. Therefore, Scheme 1 predicts that unblock may be favored by
conditions that increase Po, whereas Scheme 2 predicts
that the rates of recovery will only depend on dissociation of paxilline from closed conformations. However,
in accordance with Scheme 1, given that paxilline has a
strong effect on the C-O equilibrium, i.e., Ep of 0.002,
the C to O transition for paxilline-bound channels may
still be sufficiently small so that unblock only arises from
paxilline unblock from closed channels.
To examine unblocking kinetics, we first allowed
block in 100 nM paxilline to develop at 80 mV with
300 µM Ca2+. We then examined unblock from paxilline either after a change to an equilibration condition
of higher Po in the constant presence of paxilline or
after washout of paxilline. Recovery of channels from
paxilline inhibition was assessed by brief test steps to
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difference in paxilline concentration was associated with
a 1.6-fold different in recovery time constant. This weak
concentration dependence seems curious given the
similarity of recovery from inhibition by 100 nM paxilline, when recovery occurs either with or without paxilline. We potentially attribute this difference to the idea
that channels recovering at 0 mV from inhibition by
20 nM paxilline begin with only slightly more blocked
channels than unblocked channels, whereas channels
recovering with 100 nM paxilline start primarily from
blocked states. We noted above that the time course of
inhibition onset at intermediate Po levels exhibits some
complexity, perhaps reflecting the contributions of multiple transitions to the observed relaxations. We suggest
that the same may apply when comparing unblock at
20 nM paxilline to that at 100 nM paxilline.
Collectively, these tests show that conditions of increased Po only weakly increase the rate of recovery
from paxilline inhibition and only at the most positive
Po’s. The absence of any obvious effect of conditions
favoring channel opening on unblock at potentials negative to 0 mV suggests that, under such conditions, inhibition by paxilline is defined solely by the rates of
association to and dissociation from the closed channels. Excluding the possibility that paxilline binding is
directly influenced by voltage and/or Ca2+, we favor the
view that the weak Po dependence of unblock rate at
positive voltages is consistent with Scheme 1; that is,
some closed channels bound with paxilline recover by
first opening, which then permits faster dissociation of

Manipulation of BK Po by MTS modification of S6 residues also modulates paxilline sensitivity. (A) Traces on the top show that 100 nM paxilline
readily blocks Slo1-A313C currents, but after modification of A313C with MTSET, paxilline produces
hardly any block of the residual current. (B) The
normalized conductances from the experiment
shown in A are plotted for A313C in the absence
and presence of paxilline, and then after modification by MTSET. Slo1-A313C-MTSET is constitutively
active over the potentials examined. (C) Results are
shown for Slo1-A313C before and after modification
by MTSEA. Modification by MTSEA produces less
G-V shift than for modification by MTSET, whereas
block by paxilline is also intermediate. (D) Similar
results are shown for Slo1-A313C before and after
modification by MTSES. MTSES produces only modest shifts in the BK G-V and has little effect on block
by paxilline.

Figure 11.
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revealing essentially no difference in recovery time course
among these three conditions.
Analysis of recovery time course can also be useful
in distinguishing among different types of inhibitory
mechanisms. The single-exponential nature of the recovery time course is consistent with a single rate-limiting
step, perhaps paxilline unbinding, underlying the recovery as embodied in Scheme 1. A different category of
model not considered in the analysis of steady-state inhibition would involve multiple, identically bound paxilline molecules, each of which must dissociate before
unblock occurs. In such a case, the time course of recovery is expected to exhibit a lag, consistent with the number of recovery steps. However, we found that the recovery
time course, when defined by I(t) = (1  exp(t/tau))n,
consistently yields values near 1 (Fig. 10 C), whereas
constraining n = 2 or 4 totally fails to describe the recovery time course. Thus, there is no indication of any delay
in the onset of a single-exponential unblocking process.
Mean values from similar recovery experiments revealed little obvious difference in unblocking time constants from 80 to 0 mV, with only a modestly faster
time constant at more positive voltages (Fig. 10 D). It is
noteworthy that, after a change in the voltage to allow
unblock to occur, the recovery time course is essentially
identical whether paxilline remains in the solution or is
washed out. However, in another set of seven patches,
we explicitly measured recovery at 0 mV in the constant
presence of paxilline, with paxilline either at 20 or 100 nM
(red symbols in Fig. 10 D). In this case, the fivefold
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paxilline, reflecting the very weak affinity of paxilline to
the open channel. That unblocking rates are not more
strongly Po dependent suggests that paxilline unbinding from closed states is still relatively rapid compared
with opening of the paxilline-closed state, even at positive voltages and high Ca2+.
The above interpretation suggests that the time constants of recovery measured at negative voltages reflect
the dissociation rate of paxilline from closed channels.
The mean time constant at 80 mV of 37.0 s corresponds to a rate of 0.027/s. From the forward rate of
paxilline block to closed channels of 2.1 × 106 M1s1
(Fig. 9 F), the affinity of paxilline to the closed BK channel calculated from the kinetic estimates is 12.9 nM, in
quite satisfactory agreement with the estimates of paxilline affinity for the closed channel based on inhibition
of steady-state currents (Fig. 6 E).

MTS modification of a cysteine introduced at A313 in
the BK S6 helix shifts BK G-V curves to more negative
potentials (Zhou et al., 2011). The extent of the gating
shift depends on the MTS reagent, with MTSET resulting in the largest shifts. We therefore wondered whether
gating shifts produced by the MTS reagents might alter
paxilline sensitivity in a fashion consistent with the Po
dependence of paxilline block. We first defined the
paxilline sensitivity of the unmodified A313C construct
(Fig. 11, A and B). 100 nM paxilline resulted in strong
block of the Slo1-A313C current. The application of
100 µM MTSET resulted in an irreversible modification
of the Slo1-A313C current with strong current rectification at positive potentials, reflecting a voltage-dependent
reduction of single-channel conductance by the MTSET
attached to A313C (Zhou et al., 2011). Furthermore,
modification by MTSET produces an essentially constitutive activation of current at negative potentials (Fig. 11 A),
as indicated by G-V curves generated from the Slo1A313C-MTSET tail currents (Fig. 11 B). The application
of 100 nM paxilline to the MTSET-modified channel
produced only a small reduction in current (Fig. 11 A).
The Po of the MTSET-modified Slo1-A313C channels
was 0.9 at 0 mV with 10 µM Ca2+, whereas the fractional block by paxilline was <0.1.
The disruption of paxilline inhibition of the MTSETmodified channel might arise either from the inability
of paxilline to inhibit open BK channels as developed
above or from inhibition by MTSET of access of paxilline to its blocking site. To further address this issue, we
examined the consequences of modification of A313C
by either MTSEA (Fig. 11 C) or MTSES (Fig. 11 D).
Modification of A313C by the neutral MTSEA resulted
in a substantive leftward shift in BK gating, but not
as strong as that after modification by MTSET. After


Access of paxilline to its blocking position is hindered
by compounds thought to occupy the inner pore

The ability of the G311S mutation to disrupt paxilline
blockade and the key role of Slo1 S6 in inhibition by
paxilline suggest that the BK channel central cavity may
play a role in paxilline blockade (Zhou et al., 2010).
Furthermore, the results showing that binding of a single paxilline molecule produces inhibition also suggest
an action of paxilline on the axis of the permeation pathway. To further address this issue, we have asked whether
compounds known to occupy the BK inner pore may
hinder paxilline inhibition. We used two different tests:
first, examination of the onset of paxilline inhibition in
the presence of a bulky pore blocker; and second, examination of the ability of sucrose, an impermeant solute known to occupy the BK inner cavity (Brelidze and
Magleby, 2005), to impede paxilline inhibition.
As a BK channel pore blocker, we used the bulky molecule N-(4-[benzoyl]benzyl)-N,N,N-tributylammonium
(bbTBA), which has been shown previously to block
both open and closed BK channels (Wilkens and Aldrich,
2006; Tang et al., 2009). For any pair of pore blockers,
if one determines the steady-state block produced by
each agent producing near half-maximal block, examination of the blocking effects of both applied together
potentially allows discrimination between competitive
and noncompetitive mechanisms. In fact, this was used
to show that inhibition of BK channels by TBA and
bbTBA occurs in a competitive fashion (Wilkens and
Aldrich, 2006). However, this approach works best for
rapid blockers, where onset and recovery from block allows ready determination of the fractional block under
any condition. In the present case, we are coupling a
faster blocker, bbTBA, with a slower blocker, paxilline.
As a consequence, we chose a different strategy that
takes advantage of the fact that the washout of bbTBA
Zhou and Lingle
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Pore modification with MTS reagents alters paxilline
inhibition in a fashion consistent with the inverse
dependence of inhibition on Po

modification, the BK fractional Po at 0 mV and 10 µM
Ca2+ was 0.48, whereas 100 nM paxilline produced a
fractional block of 0.5. Modification of Slo1-A313C by
the negatively charged MTSES resulted in a modest leftward gating shift, and inhibition by 100 nM paxilline of
the modified channels (Po at equilibration conditions
was 0.12) was only slightly weaker than that for inhibition of the unmodified Slo1-A313C channels.
Although the three MTS reagents differ in net charge
conferred on the modified Cys residue, they are of
generally similar size. Give that paxilline is neutral at
physiological pH, it seems highly unlikely that the differences among MTS moieties on the extent of paxilline inhibition reflect either electrostatic or steric
hindrance of paxilline binding. On the other hand,
the reduction in paxilline sensitivity of MTS-modified
A313C channels provides further support for the view
that inhibition by paxilline is inversely correlated with
increases in channel Po.
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number of channels blocked by paxilline was reduced
50%. The fractional reduction of block is about that
expected for a competitive model for each compound
being applied at 10-fold their estimated dissociation
constants.
One simple interpretation of this result would be that
the presence of bbTBA in the BK central cavity prevents
or slows access of paxilline to its blocking position. However, it might also be considered that perhaps bbTBA
reduces paxilline inhibition because the presence of
bbTBA in the inner cavity mimics a BK channel open
conformation, which we have shown above has reduced
affinity for paxilline. We consider the latter possibility
unlikely because of three factors: first, under the equilibration conditions of this experiment (0 mV, 10 µM
Ca2+), the BK Po is low (0.05), such that channels are
predominantly in closed states; second, under these conditions, bbTBA will occupy both open and closed channels with about equal affinity (Wilkens and Aldrich,
2006; Tang et al., 2009); and third, bbTBA has minimal
ability to hinder the BK channel open-to-closed transition, so it is unlikely that it stabilizes the open conformation (Wilkens and Aldrich, 2006; Tang et al., 2009).
In our second test, we used 2 M sucrose, which has
been shown to produce a marked reduction of outward
potassium flux through BK channels, largely from bulk
occupancy of the BK channel central cavity (Brelidze
and Magleby, 2005). We first confirmed this effect of
2 M on macroscopic BK currents (Fig. 12 B), which
bbTBA and sucrose each slow paxilline
inhibition. (A) Blockade of Slo1 current by 100 nM
paxilline is displayed with and without simultaneous application of 100 µM bbTBA. The equilibration conditions were 0 mV with 10 µM Ca2+, and BK
current availability was monitored by voltage steps
to 160 mV applied at 1 Hz. Blocker applications are
shown with horizontal bars, with all measurements
from the same patch. Block and unblock with 100 µM
bbTBA alone (black) is rapid, whereas block by
100 nM paxilline (red) alone exhibits slow onset
and recovery. After simultaneous application of paxilline with 100 µM bbTBA, the amount of paxilline
inhibition is reduced about half. (B) BK currents
were activated with 300 µM Ca2+ with the indicated
voltage protocol without and with the addition of
2 M sucrose to the cytosolic solution. Insets show
currents with a red trace at 20 mV. Sucrose markedly reduces outward current, whereas tail currents
at 120 mV are reduced a little more than half. For
control solutions, Vh = 16.3 ± 7.2 mV, whereas with
2 M sucrose, Vh = 12.8 ± 3.3 mV. (C) 100 nM paxilline strongly inhibits BK current, whereas in 2 M
sucrose, both outward and inward currents are only
slightly affected by paxilline. Top traces are single
sweeps. Bottom traces correspond to an average
of 15 sweeps before, during, and after washout of
100 nM paxilline. (D) Plot of time course of paxilline inhibition without and with 2 M sucrose suggests
that sucrose slows the development of inhibition
by paxilline.
Figure 12.
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will be essentially complete before any channels blocked
by paxilline will have unblocked. Reasoning that channels,
once blocked by paxilline, will recover from paxilline
inhibition slowly, we examined whether the presence of
bbTBA might reduce the fraction of channels blocked
by paxilline.
We used 100 µM bbTBA, a concentration that exceeds the channel blocking affinity by 10-fold (Wilkens
and Aldrich, 2006; Tang et al., 2009). An advantage of
the use of bbTBA is that it has been shown to occupy
both closed and open BK channels. We then examined
block by 100 nM paxilline, which is also near 10-fold the
estimated affinity of block for the closed BK channel.
An example of such an experiment is shown in Fig. 12.
Currents were activated by voltage steps to 160 mV
under equilibration conditions of 0 mV and 10 µM Ca2+.
100 µM bbTBA was first applied to the patch to establish
the time course of bbTBA block and unblock. 100 nM
paxilline was then applied to the patch for 40 s and
then washed out. Block was incomplete but current was
reduced 80% before washout. Subsequently, 100 µM
bbTBA was applied simultaneously with 100 nM paxilline for the same duration of application as with 100 nM
paxilline alone. With both agents together, currents are
completely blocked. However, upon washout, currents
return to a level 50% of the blocked level observed
with paxilline alone, and then slowly recover with a time
course characteristic of unblock from paxilline. This
indicates that, in the presence of 100 µM bbTBA, the
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Paxilline does not alter the ability of MTSET
to modify A313C

Although the above experiments show that paxilline inhibition is hindered by bbTBA and sucrose, they do not
address whether paxilline hinders inhibition by bbTBA

or inner cavity occupancy by sucrose. To address whether
paxilline may hinder access of small molecules to the
central cavity, we again took advantage of the ability of
MTSET to modify pore residue A313C, both in open and
closed states (Zhou et al., 2011). Modification of A313C
by 1 mM MTSET of closed BK channels occurs with a
time constant of 23 s and is associated with a >50% reduction in maximal conductance, as a result of effects on
single-channel conductance (Zhou et al., 2011). Modification of A313C in open states is 200-fold more rapid.
Here, because our results suggest that paxilline may only
act on closed BK channels, we specifically asked whether
the presence of paxilline would hinder the ability of residue A313C to be modified by MTSET when channels
are closed. First, we confirmed the extent of modification
of closed (80 mV, 0 Ca2+) A313C channels by a 120-s
application of 1 mM MTSET in the absence of paxil
line (Fig. 13 A). For a time constant of 23 s, modification
should be >99% complete at 120 s. The G-V curve after
MTSET modification (Fig. 13 C) exhibits a substantial
shift as observed previously, although less shifted than
reported previously for open-state modification of A313C
(Zhou et al., 2011). In separate patches, we then examined whether 500 nM paxilline hindered modification
by a similar application of MTSET (Fig. 13, B and C).
We found no difference in modification with or

Figure 13. Paxilline does not
hinder MTSET modification of
A313C. (A; top) The traces show
currents activated with 300 µM
Ca2+ at voltage steps up to 200 mV
for channels arising from Slo1C430S-A313C. (Bottom) Currents were similarly elicited, but
after 120 s of application of 1 mM
MTSET while holding the patch
at 80 mV with 0 Ca2+. (B; top)
The traces show current for Slo1C405A-A313C activated with
300 µM Ca2+. The patch was then
first perfused with 500 nM paxilline for 100 s while holding at
80 mV with 0 Ca2+, and then
exposed to 1 mM MTSET with
500 nM paxilline for 120 s while
still at 80 mV with 0 Ca2+. (C) G-V
curves summarize results from
patches examined for conditions shown in A and B. Because
MTSET modification was tested
both without and with paxilline,
two separate sets of control G-V
curves at 300 µM Ca2+ are shown.
(D) BK currents were recorded
in 300 µM Ca2+ before (left) and
after (top right) modification by
1 mM MTSET, applied for 120 s in 0 Ca2+ at 80 mV. Modification is similar to that in A. The patch was then held at 0 mV, 0 Ca2+, and
then channels were opened by 20 100-msec steps to 160 mV, after which the traces on the bottom right were obtained in 300 µM Ca2+.
(E) G-V curves correspond to conditions as in D for control, after closed-state modification by 1 mM MTSET, and then after subsequent
open-state modification by the same MTSET solution.
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showed that sucrose markedly suppressed outward currents, with a weaker effect on inward K+ current. Analysis of the tail currents monitored at 120 mV revealed
little shift in the Vh of activation (Fig. 12 B). The application of 100 nM paxilline before the addition of sucrose to the cytosolic solution produced the expected
robust inhibition of current, whereas with 2 M sucrose
added to the cytosolic solution, only a weak inhibition
of BK current was observed with paxilline (Fig. 12 C).
The time course of onset of paxilline inhibition with 2 M
sucrose suggests that inhibition develops more slowly in
paxilline (Fig. 12 D), also consistent with the idea that
the presence of sucrose in the central cavity may impede
access of paxilline to its final binding position.
With the assumption that bbTBA and sucrose do not
exert any effects independent of the central cavity, collectively, the bbTBA and sucrose experiments support
the idea that paxilline is hindered from reaching its inhibitory position, when the central cavity is occupied by
other bulky molecules.
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DISCUSSION

These results describe a mechanism of inhibition of BK
channels that, to our knowledge, is unique not only for
BK channels but also for other K+ channels. In short,
434

Paxilline stabilizes closed states of BK channels

the results suggest that the binding of small molecules
to an ion channel can produce channel inhibition by
stabilization of the closed-channel conformation, without any occlusion of the open-channel ion permeation
pathway or effects on voltage sensors. An implication of
the strong closed-state dependence of the inhibition is
that the ability of paxilline to inhibit BK current among
different cells will vary depending on the resting Po in a
given cell. Thus, some caution may be required in the
application of paxilline as a diagnostic tool for the presence of BK channels, if BK subunit composition and
resting Ca2+ is such that the resting Po is high. Below, we
consider the paxilline inhibitory mechanism within the
context of other channel inhibitory mechanisms and
discuss our results in terms of potential structural bases
of the paxilline effects.
Categories of closed-channel block

In “open-channel block,” upon channel opening, a
blocking molecule simply moves from bulk solution
into a position within the central axis of an ion permeation pathway that physically occludes ion permeation.
In contrast, “closed-channel block” may include any of
a variety of allosteric effects, often occurring in association with direct blocking effects. For many blockers for
which a closed-channel block effect has been described,
the underlying mechanisms remain largely unknown
and, in most cases, a compound will produce both openand closed-channel block effects.
The simplest category of closed-channel blocker is
one in which the blocker is able to access a position in
the closed channel that, once the channel opens, will
occlude ion permeation. This might occur in either of
two ways: first, lipophilic molecules may pass through
hydrophobic pathways to reach a position suitable for
pore occlusion, as originally proposed for uncharged
local anesthetics acting on Na+ channels (Hille, 1977);
and second, some channels may have a relatively accessible inner cavity allowing access of charged blocking
molecules both in closed and open states, as proposed
for blockade of BK channels by bulky quaternary blockers (Wilkens and Aldrich, 2006; Tang et al., 2009).
The idea that lipophilic blocking agents might access
blocking sites within closed ion channels was probably
first considered in classical studies of local anesthetic
block of Na+ channels in the node of Ranvier (Hille,
1977). This work suggested that both charged and uncharged anesthetics reached a similar blocking position
within the channel but reached the blocking site by distinct pathways: charged species required the opening of
a cytosolic gate to reach a blocking position, whereas
uncharged species are able to reach the same blocking
position via a hydrophobic region of the protein. This
idea that both categories of compounds reach similar
positions within the Na+ channel aqueous cavity has
recently been supported in modeling work (Bruhova
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without paxilline, although BK current was completely
inhibited by paxilline during the application of
MTSET. At 500 nM paxilline and a paxilline-binding
constant of 10 nM, channels will be occupied by paxilline 98% of the time. If MTSET can only modify BK
channels during that 2% of the time that paxilline is
not present, based on the previously defined rate of
MTSET modification of closed channels, essentially no
modification by MTSET should be observed. This result therefore clearly shows that paxilline does not hinder MTSET modification of position A313C in closed
BK channels.
Given that the partial G-V shift observed for MTSET
modification of closed channels differs from the essentially constitutive activation of BK channels modified
by MTSET while in open states (Zhou et al., 2011), we
wondered whether the partial modification might simply reflect loss of reactive MTSET during the 120 s of
MTSET application. To address this issue, a set of
patches was first modified by MTSET while channels
were held in closed states by bathing the patch in 0 Ca2+
at 80 mV (Fig. 13 D). Subsequently, the same MTSET
solution was then applied while channels were held in
high Po conditions. This was accomplished by changing
the holding condition to 0 mV at 0 Ca2+ but applying
20 voltage steps to 160 mV, each of 100-ms duration. In
this case, additional modification by MTSET readily occurred resulting in channels that are essentially constitutively open over a wide range of voltages, similar to
the earlier observations (Zhou et al., 2011). This indicates that channels modified by MTSET while in closed
states have different gating properties than those modified in open states. Using single-channel recordings,
our previous work showed that two distinct step changes
in single-channel current can be observed during modification of A313C by MTSET (Zhou et al., 2011), presumably corresponding to the sequential modification
of at least two distinct A313C cysteines. We therefore
propose that in the closed BK channel, the dimensions
of the inner cavity are such that modification by only a
single MTSET can be accommodated. In contrast, in
the open channel, the volume allows modification at two
A313C positions. The differences in the gating shifts
after closed- and open-state modification reflect the effects of modification at either a single subunit or a pair
of subunits. Regardless of this nuance of MTSET modification at position A313C, the important point is that
wherever the position of paxilline inhibition, it does
not hinder the ability of MTSET to modify at least one
A313C residue.
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particular, might have evolved to exploit other ways of
stabilizing channels in closed states.
Considerations regarding the physical basis
of paxilline inhibition

The paxilline inhibition of BK channels appears to exhibit features unique among previously reported closedchannel blocking effects on K+ channels. First, the
closed-channel block effects occur in the almost complete absence of open-channel block. Second, the paxilline inhibitory effect can be described by allosteric
regulation of the central C-O equilibrium. Do the present results allow for any inferences regarding the physical basis for such effects? In the absence of structural
information, definitive answers regarding the paxilline
site of action are not possible. However, here we consider
two topics: first, the route of paxilline access to its inhi
bitory positions; and second, the number of paxillinebinding sites on a channel.
For a lipophilic molecule like paxilline (logP = 3.62),
it is natural to wonder whether paxilline reaches its position of inhibition from the paxilline reservoir in the
membrane. Several results are pertinent to this topic.
The ability of both the bulky pore blocker, bbTBA, and
high concentrations of the impermeant solute, sucrose,
to impede paxilline inhibition would seem to argue
against the possibility that paxilline reaches its site of
inhibition via the bulk lipid membrane. Neither bbTBA
nor sucrose would be expected to impede the partitioning of paxilline into lipid or movement from lipid into
channel protein. We consider it less likely that inter
ference of bbTBA and sucrose of paxilline inhibition
would arise, because of some steric effect of pore occupancy preventing lateral diffusion of paxilline through
the protein into an inhibitory position.
Our measurement of the paxilline concentration
dependence of inhibition of closed channels may also
provide insight into the source of paxilline-mediating
inhibition. We measured a forward rate of inhibition
that was linear up through 2 µM paxilline with a slope
of 2 × 106 M1s1. This is very similar to rates of openchannel block of several other ion channels, both for
uncharged anesthetics (Adams, 1976) and for charged
anesthetics at 0 mV (Neher and Steinbach, 1978; Lingle,
1989). For bbTBA block of BK channels, at 100 mV the
forward rate of block is 1.2 × 108 M1s1 (Wilkens and
Aldrich, 2006). Assuming a z of 0.148 e assigned to the
forward rate, this reflects a 0-voltage forward rate of
6.7 × 107 M1s1. This is faster than what we observe for
paxilline inhibition in closed states, but experiments
examining state-dependent modification of cysteines
introduced into BK S6 reveal a more than two orders of
magnitude difference for MTS modification rates of
residues in open versus closed channels (Zhou et al.,
2011). The linearity of the rate as a function of paxilline
concentration suggests that, even when channels are
Zhou and Lingle
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et al., 2008). More recently, it has become clear that
local anesthetics may exert two types of effects on Na+
channels: one involving allosteric effects on voltage sensors, and a second corresponding to more traditional
pore occupancy and occlusion (Hanck et al., 2009;
Muroi and Chanda, 2009).
For closed-channel inhibition of BK channels, bbTBA
and other quaternary blockers appear to gain access to
the central cavity of the pore in both open- and closedchannel conformations (Wilkens and Aldrich, 2006;
Tang et al., 2009), with little difference in apparent affinities of interaction for open and closed channels.
The idea that the BK central cavity is accessible in closed
states has also been supported by work showing that cysteine residues introduced in the BK S6 at positions that
would be expected to be inaccessible in closed Kv channels can be readily modified by charged MTS reagents,
even in closed states in BK channels, albeit at rates
slower than the modification of open channels (Zhou
et al., 2011). The closed-channel inhibition of BK channels by bbTBA, like that of local anesthetics on Na+ chan
nels, represents essentially a simple pore occupancy
model, with little difference in block between closed
and open states.
For the two types of two cases of closed-channel block
just described, both open- and closed-channel block
contribute to the overall channel inhibitory effect. However, an interesting case of closed-channel block that
deviates from this generality is that of tetracaine inhibition of CNG channels (Fodor et al., 1997a,b) for which
the affinity of tetracaine for closed channels is 1,000fold stronger than for affinity to open channels. CNG
channels share with BK channels the ability for molecules to enter the inner cavity in both open and closed
states, allowing modification of pore-lining–introduced
cysteines (Flynn and Zagotta, 2003). For inhibition by
tetracaine, inhibition has been suggested to arise from a
snug fit within the CNG inner cavity, but the conformational changes within the inner cavity favor binding to
the closed state, but not to the open (Fodor et al., 1997a).
Intriguingly, mutation of E363G, a residue presumably
on the extracellular end of the CNG selectivity filter,
abolishes the state dependence of tetracaine inhibition
(Fodor et al., 1997a), supporting the idea that closedstate inhibition by tetracaine involves a snug positioning
of tetracaine in the vicinity of the selectivity filter.
In contrast to the pore occupancy models or occlusion by toxins on the extracellular face of channels,
closed-channel block by voltage-sensor toxins, such as
hanatoxin (Lee et al., 2003), represents the perhaps
clearest example of a compound acting at positions that
are not in the axis of the ion permeation pathway, such
that the inhibition of channel activation clearly must be
allosteric. Given the allosteric nature of ion channel
proteins, it would not be surprising if natural toxins, in
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of recovery from inhibition, as each of the up to four
paxilline molecules must unbind before unblock occurs. This is not observed.
If the binding of a single paxilline molecule does produce BK channel inhibition, this is most consistent with
a binding site that is located along the axis of the permeation pathway. In the present case, this possibility is
given some support by both the bbTBA and sucrose results. A caution to this idea is the possibility that the
hydrophobic bbTBA and the bulk effects of the high
solution concentration with sucrose might conceivably
hinder the action of a compound at other positions unrelated to their pore occupancy. However, at present,
there is no precedent for such alternative effects, so the
idea that bbTBA, sucrose, and paxilline interact within
or in close juxtaposition to the pore would seem the
most likely situation.
However, the one result that raises some question in
regards to the idea of paxilline inhibition involving a
single site along the axis of the permeation pathway is
the failure of paxilline to prevent MTSET modification
of position A313C in closed conformations. This result
clearly argues against one simple view of paxilline action, namely that paxilline acts to occlude the entrance
to the inner cavity, but only in the closed states (Fig. 14 A).
We think it unlikely that this result can be explained by
the possibility that both paxilline and MTSET might simultaneously occupy positions in the inner cavity. Overall, is there a way to reconcile the ability of bbTBA and
sucrose to hinder paxilline inhibition with the lack of
effect of paxilline on MTSET modification? We see no
obvious simple explanation for this set of results based
on our current understanding, but point to two possibilities. First, for BK, essentially nothing is known about
the positioning of S6 helices as they traverse from the
membrane-associated pore-gate domain to link with the
appended cytosolic ligand–sensing domain. Do the cytosolic ends of the inner helices define a tightly packed
funnel through which any permeant ion or blocker
must pass to reach the central cavity, or is there some
splayed arrangement of the cytosolic ends of the helices
that may allow passage of solutes both down and between the helices to reach the central axis of the permeation pathway? In the latter case, even if a compound
were to occupy a position within the tetrad of inner helices, thereby stabilizing a closed conformation, perhaps pathways for compounds to reach the inner cavity
might still exist (Fig. 14 B). Assuming strict homology of
the pore-gate domain of the Slo1 family of channels to
Kv channels, this possibility would seem unlikely. However, many examples now exist of ways that the BK S6
helix and inner cavity differ from that of Kv channels.
For example, residues that are likely to be pore facing
in BK differ from those in Shaker (Chen and Aldrich,
2011; Zhou et al., 2011; Chen et al., 2014). Similarly, the
pattern of modifiability of BK S6 residues differs from
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largely closed, a single step, perhaps diffusionally controlled encounter appears to define the block kinetics.
That this rate is comparable to what is observed for
open-channel blockers suggests that it reflects block occurring from the aqueous milieu. However, does the
linearity and magnitude of the blocking rate fully exclude the possibility of inhibition occurring from lipid?
Linearity in the rate implies that, over this concentration
range, inhibition arises from the binding of paxilline
directly to the inhibitory position, whatever the source
of paxilline may be. However, for paxilline reaching an
inhibitory position from bulk lipid, deviation from linearity would probably be expected, if the pathway to the
paxilline inhibitory position involved transient occupancy of hydrophobic pockets along the route to the
binding site. Although our results do not require a particular explanation, we prefer the view that the effects
of bbTBA, sucrose, and linearity in inhibition are most
readily explained by paxilline inhibition occurring from
the aqueous milieu.
We now address the question of the number of high
affinity, closed-state paxilline-binding sites per BK channel. The concentration dependence of paxilline inhi
bition based on a specific allosteric model of channel
inhibition (Scheme 1) suggests that inhibition arises
from the binding of a single paxilline molecule to
closed channels with an affinity of 10 nM. This conclusion rests largely on the shape of the concentration–
response curves at the highest Po values and highest
paxilline concentrations. Schemes with multiple, identical paxilline-binding sites predict weaker inhibition at
higher paxilline than we observed (Fig. 7). Based on
the particular technical challenges in defining fractional inhibition at high Po and paxilline, the measures
of paxilline inhibition are more likely to be underestimates than overestimates. This provides some additional
confidence that the single-site model is most likely. However, one caution regarding the single-site mechanism is
the possibility that, at the highest paxilline concentrations, an additional, independent paxilline inhibitory
effect might occur. If that were the case, this would prevent any assertions regarding the number of identical,
high affinity paxilline sites based on the Po dependence
of paxilline concentration dependence.
An additional consideration relevant to this point is
that, if paxilline were accessing its binding sites by coming in laterally through the protein, we would expect
that up to four paxilline molecules would be able to occupy such positions simultaneously. Yet, as noted, the
concentration dependence of paxilline action is best
explained by the action of a single paxilline molecule. If
four paxilline molecules could bind to the channel,
with one being sufficient for a full inhibitory effect, this
would also be consistent with the observed steady-state
results. However, for recovery from inhibition, unbinding from four sites would predict a lag in the time course
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that in Shaker (Zhou et al., 2011). As such, perhaps the
difficulty in reconciling the bbTBA/sucrose results with
the inability of paxilline to protect against MTSET modification arises from some other unusual aspect of the
BK S6 and pore-gate domain that differs from the now
classic Kv pore-gate domain motif. A second potential
explanation is that perhaps paxilline does bind near the
entrance to the closed-channel inner cavity, but in a

The role of G311 in inhibition by paxilline

Cartoons describing possible views of inhibition of
closed BK channels by paxilline. (A) Schematic BK channels are
either closed (left pair) or open (right pair). The channels are
diagrammed with an opening at the cytosolic end of the channel, which allows small molecules in and out of the inner cavity.
Paxilline occludes the aperture to the inner cavity in the closed
BK channel. Binding of paxilline to the closed channel (bottom
left) occludes the aperture to the inner cavity. The open conformation either is unable to bind paxilline or does so with low affinity, without any occlusion of ion permeation. Dotted arrows
indicate transitions that are either very low probability or do not
occur. (B) Overall scheme is the same as in A, except for positions
of inner-pore helices along alternative aqueous pathways for access of small molecules to the inner cavity. Thus, occlusion of the
closed-channel aperture by paxilline may not impede access of
small molecules to the inner cavity, such that MTS reagents can
modify position A313C.

Figure 14.



The effect of mutation of G311 on paxilline sensitivity
(Zhou et al., 2010) is unusual among all manipulations
of BK channels we have examined. Namely, mutation of
G311 is the only manipulation causing a rightward shift
in BK activation at a given Ca2+ that is also associated
with a decrease in paxilline effectiveness. This indicates
that the effect of G311 mutation is not the result of state
dependence, but the result of some specific change
altering paxilline binding or effect. Interestingly, the
pH-regulated Slo3 K+ channel is resistant to paxilline
inhibition and also lacks the corresponding hinge glycine, whereas the S300G mutation in Slo3, the hinge
position, restores some paxilline sensitivity.
Is there a relationship between the ability of mutation
of G311 to abolish paxilline block and the lack of block
of open BK channels? G311 corresponds to a conserved
glycine found in a large number of both eukaryotic and
prokaryotic voltage-gated K+ channels (Magidovich and
Yifrach, 2004). Because mutations at this position alter
the C-O gating equilibrium of channels where it has
been studied, this glycine has been termed a “gating
hinge” (Yifrach and MacKinnon, 2002; Magidovich and
Yifrach, 2004), and a bend in the S6 helix has been observed at this position in K+ channel structures (Jiang
Zhou and Lingle
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position that does not hinder MTSET access to the inner
cavity. If paxilline occupied a position near the entrance
to the inner cavity, bbTBA, which is perhaps large
enough to fully occupy the inner cavity, may hinder
paxilline movement to its blocking position. Why the
smaller sucrose might also reduce paxilline inhibition is
less readily explained, except perhaps by the idea that
sucrose at 2 mM may simply displace a sufficient volume
to reduce the effective paxilline concentration near the
mouth of the channel.
The uncertainties associated with reconciliation of
the bbTBA and sucrose results and absence of effect of
paxilline on MTSET modification of closed states leaves
open the question of whether paxilline does act along
the axis of the permeation pathway. Given that paxilline
can still produce inhibition in channels with MTSESmodified A313C makes it unlikely that paxilline interacts somewhere deep in the inner cavity. The failure of
paxilline to hinder MTSET modification of closed states
seems to argue against occlusion of the closed channels,
except perhaps as modeled in Fig. 14 B, for which there
is no precedent. If inhibition occurs at a position that is
not on the axis of the permeation pathway, one has to
consider that there may be four distinct paxilline-binding sites per channel. Yet, our analysis of the concen
tration dependence of paxilline inhibition supported
a single-site model (Fig. 7 A). At present, our results do
not allow a clear-cut answer on this point, and future
functional or structural work that identifies residues
likely to interact with paxilline will be required.
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Implications of the state dependence of paxilline inhibition
for practical usage of paxilline

It has been reported that paxilline or related alkaloids
may alter the G-V curves for BK channel activation. The
considerations presented here indicate that, once a given
equilibration condition is established, if test steps are
brief, no change in G-V will occur. However, given the
slow equilibration rates, it is easy to see how under some
experimental conditions apparent shifts in G-V curves
might be observed. For example, for examination of BK
channels, one might hold a patch at 0 mV, but then,
when generating a G-V curve, briefly step to 80 mV
(or more negative potentials) between test steps from
80 to 200 mV. If during paxilline application, one
holds the patch at 0 mV before applying the test protocol, the block equilibrium established at 0 mV will then
be altered by the new 80-mV holding level. Given the
slow change in the inhibitory equilibrium, initial test
steps will more reflect the equilibrium at 0 mV, whereas
later steps will approach the equilibrium occurring at
80 mV. How this would exactly impact on a G-V curve
would depend on the sequence of test voltages, but the
point is that without maintaining the same equilibration conditions before and during a test sequence, G-V
curves will be altered. Regardless of whether such an
explanation may account for some earlier observations
of shifts in G-V curves, it is clearly the case that protocols
must take into account that the extent of paxilline inhibition depends on the Pc of the equilibration conditions. Furthermore, the specific equilibration conditions
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must be clearly defined and maintained during steps
that evaluate the extent of paxilline inhibition.
The state dependence of paxilline inhibition may also
require caution in the use of paxilline as a tool for identification of the contributions of BK current in various
cell types. An implication of the present results is that
gating shifts produced by either  or 1 subunits may
reduce the effectiveness of paxilline, because of the unusual state dependence of paxilline inhibition and not
because of a subunit-specific effect. Work in progress
supports this idea (unpublished data). In most cases,
this will probably not be a problem, as normal cellresting potentials and normal intracellular Ca2+ con
centrations will usually ensure that paxilline inhibition
will be effective. However, if a particular stimulus paradigm results in robust cellular depolarization and Ca2+
elevation over tens of seconds, this may be sufficient to
reverse inhibition by paxilline such that the role of BK
channels may be partially obscured with particular subunit combinations.
Summary

Inhibition of BK channels by paxilline involves strong
stabilization of closed conformations, with paxilline affinity for closed channels being 1,000-fold stronger
than for open channels. Various criteria suggest that
paxilline reaches its blocking position from the cytosolic aqueous milieu, perhaps involving an interaction
near the entrance to the inner cavity. The unusual state
dependence of paxilline inhibition requires caution in
the use of paxilline in cellular systems, where conditions of Po of the BK channels may not be well known.
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